Have you travelled to an area where the Zika virus is present?

Click here for a map of areas with Zika.


Updated JULY 2019:

The CDC, in collaboration with FDA, has developed a process to define areas at increased risk for Zika virus transmission within the U.S. and throughout the world.


Within the U.S:

The US is the only country for which we have current, accurate information regarding Zika risk. There is no current local transmission of Zika virus in the continental United States as of February 28, 2019. This includes Florida and Texas, which last reported local transmission of Zika virus by mosquitoes in 2016-17. No Zika virus transmission by mosquitoes has ever been reported in Alaska and Hawaii. This information is subject to change. An up-to-date list of Zika virus transmission in the United states can be found at the CDC website: https://www.cdc.gov/zika/geo/index.html


Outside the U.S.

For countries and territories outside the U.S. states, the CDC has created a world map of areas with risk of Zika virus infection, which will be updated on a regular basis. This map indicates the level of risk using four different color shading:


Red: Country or territory with current Zika outbreak

Purple: Country or territory with any prior or current reports of mosquito-borne Zika transmission

Yellow: Country or territory with the vector and no reported mosquito-borne Zika transmission

Green: Country or territory with no mosquitoes that spread Zika

The CDC categorizes Red and Purple areas as those at increased risk of Zika virus transmission. Any country that reports an outbreak above baseline transmission will turn Red on the map, and the recommendation will be not to travel there. The decision of whether or not to travel to a Purple country before conception is a function of patient risk tolerance.

Asymptomatic women and men undergoing ART with possible exposure to Zika virus or who have traveled to a zone of possible Zika exposure (see 5. Areas at increased risk for Zika virus transmission, above) should wait 8 weeks for women and 3 months for men.

LINK TO FULL REFERENCE DOCUMENT: https://www.asrm.org/globalassets/asrm/asrm-content/news-and-publications/practice-guidelines/for-members/guidance_for_providers_zika_virus_exposure.pdf